Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Capricor Therapeutics Inc (NASDAQ: CAPR) closed at $14.53 in the last session, down -2.48% from day before closing price of $14.90. In other words, the price has decreased by -$2.48 from its previous closing price. On the day, 0.64 million shares were traded. CAPR stock price reached its highest trading level at $14.86 during the session, while it also had its lowest trading level at $14.21.
Ratios:
We take a closer look at CAPR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.19 and its Current Ratio is at 4.19. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on October 21, 2024, initiated with a Overweight rating and assigned the stock a target price of $35.
On May 17, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $14.
On January 05, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.Cantor Fitzgerald initiated its Overweight rating on January 05, 2024, with a $8 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 20 ’24 when Nippon Shinyaku Co Ltd bought 2,798,507 shares for $5.36 per share. The transaction valued at 14,999,998 led to the insider holds 7,090,351 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAPR now has a Market Capitalization of 660677632. For the stock, the TTM Price-to-Sale (P/S) ratio is 28.44 while its Price-to-Book (P/B) ratio in mrq is 8.58.
Stock Price History:
The Beta on a monthly basis for CAPR is 4.08, which has changed by 2.6790123 over the last 52 weeks, in comparison to a change of 0.24440956 over the same period for the S&P500. Over the past 52 weeks, CAPR has reached a high of $23.40, while it has fallen to a 52-week low of $3.52. The 50-Day Moving Average of the stock is -6.29%, while the 200-Day Moving Average is calculated to be 48.92%.
Shares Statistics:
According to the various share statistics, CAPR traded on average about 1.28M shares per day over the past 3-months and 780260 shares per day over the past 10 days. A total of 40.33M shares are outstanding, with a floating share count of 39.98M. Insiders hold about 12.08% of the company’s shares, while institutions hold 18.70% stake in the company. Shares short for CAPR as of 1735603200 were 7954663 with a Short Ratio of 6.22, compared to 1732838400 on 4412443. Therefore, it implies a Short% of Shares Outstanding of 7954663 and a Short% of Float of 19.84.
Earnings Estimates
The company has 5.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.35, with high estimates of -$0.3 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$0.47 and -$1.37 for the fiscal current year, implying an average EPS of -$1.0. EPS for the following year is -$0.78, with 5.0 analysts recommending between $1.56 and -$1.63.
Revenue Estimates
A total of 7 analysts have provided revenue estimates for CAPR’s current fiscal year. The highest revenue estimate was $46.14M, while the lowest revenue estimate was $11.14M, resulting in an average revenue estimate of $20.97M. In the same quarter a year ago, actual revenue was $25.18M
